A new study from the lab of Markey Cancer Director Mark Evers, M.D., demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine.
A recent study demonstrates that a combination of two drugs used together provides better than expected results, providing a promising treatment strategy for patients with recurrent ovarian cancer.
Lt. Gov. Coleman and several of Kentucky’s female legislators joined UK HealthCare to highlight the work of the Markey Cancer Center's Ovarian Cancer Screening Program.
The initiative aims to create a connected, integrated statewide cancer provider network. 40% of all new cancer cases in Kentucky are directly or indirectly cared for by Markey.
The partnership creates new opportunities for to better serve patients throughout Kentucky, southern Ohio and West Virginia by expanding health care services throughout the region.
Additionally, UK HealthCare was ranked as high-performing in four U.S. News adult specialties: Gastroenterology & GI Surgery, Geriatrics, Orthopedics and Urology.
A recent publication in the journal Cells demonstrated the benefit of utilizing drugs to promote radiation sensitivity in models of a rare tumor subtype.
The program offers Appalachian Kentucky high school and undergraduate students opportunities to gain cancer research, clinical, outreach and educational experiences.
